Skip to main content
. 2021 Jun 23;6(2):e21.00002. doi: 10.2106/JBJS.OA.21.00002

TABLE III.

Aggregate Postoperative Outcomes in AVBT and PSF Studies*

Outcome Pooled Mean (95% Confidence Interval)
AVBT PSF
Complication rate (%) 26.0 (12.0-40.0) 2.0 (0.0-4.0)
 <36 mo 11.8 (4.4-18.6) 1.0 (0.0-2.4)
 ≥36 mo 25.2 (19.1-31.7) 2.9 (0.5-5.3)
Reoperation rate (%) 14.1 (5.6-22.6) 0.6 (0.0-2.3)
 <36 mo 2.9 (0.0-8.4) 1.3 (0.0-1.7)
 ≥36 mo 24.7 (10.7-38.7) 1.8 (0-5.4)
Conversion to PSF (%) 1.4 (0-4.5) Not applicable
Main thoracic curve (°)
 Preop. 46.0 (42.3-50.0) 53.3 (52.8-53.9)
 First erect 24.9 (20.1-29.8) 16.6 (12.8-20.3)
 12 to <24 mo 24.6 (17.8-31.4) 13.3 (8.7-17.8)
 ≥24 to <36 mo 21.5 (8.3-34.7) 21.9 (17.4-26.4)
 ≥36 mo 22.5 (14.1-30.9) 22.7 (19.6-25.8)
Compensatory lumbar curve (°)
 Preop. 28.7 (25.6-32.0) 30.9 (29.2-32.5)
 First erect 19.3 (16.6-22.4) 9.9 (8.1-11.7)
 12 to <24 mo 16.5 (11.2-21.7) Insufficient data
 ≥24 to <36 mo 13.2 (8.4-18.0) 10.7 (8.0-13.5)
 ≥36 mo 18.0 (3.5-32.5) 15.2 (13.3-17.1)
Thoracic kyphosis (°)
 Preop. 24.3 (17.8-30.8) 23.0 (20.7-25.2)
 First erect 22.1 (16.5-27.7) 31.0 (27.9-33.3)
 12 to <24 mo 25.0 (13.4-36.6) Insufficient data
 ≥24 to <36 mo 23.0 (19.6-26.4) 17.9 (15.1-20.7)
 ≥36 mo 22.5 (12.0-33.0) 24.5 (21.9-27.1)
Lumbar lordosis (°)
 Preop. 52.0 (46.2-57.9) 47.2 (28.1-66.3)
 First erect 46.5 (40.1-52.8) Insufficient data
 12 to <24 mo 56.0 (47.2-64.9) Insufficient data
 ≥24 to <36 mo 52.7 (48.6-56.8) 46.3 (42.3-50.3)
 ≥36 mo 55.1 (51.3-58.8) 46.1 (25.0-67.1)
Thoracic rotation (°)
 Preop. 13.7 (12.1-15.2) 15.4 (12.4-18.4)
 First erect 10.0 (8.7-11.2) 6.0 (4.5-7.5)
 12 to <24 mo 8.1 (5.9-10.3) Insufficient data
 ≥24 to <36 mo 6.9 (4.8-8.9) 8.07 (5.0-11.1)
 ≥36 mo 8.4 (1.0-15.7) 13.0 (3.3-22.6)
Postop. SRS-22 self-image 4.27 (4.0-4.56) 4.23 (4.07-4.40)
Postop. SRS-22 total 4.36 (4.06-4.65) 4.30 (4.17-4.43)
*

AVBT = anterior vertebral body tethering, and PSF = posterior spinal fusion. The complication rate is reported as the minimum possible number of patients with at least 1 complication. Nonoverlapping confidence intervals for the primary outcomes of interest are highlighted in bold.